The Department of Defense is offering this grant, the FY17 VRP TTDA, to support the translation of promising preclinical vision research findings into clinical products. This grant is for developing new technologies and therapies aimed at improving detection, diagnosis, treatment, or quality of life for individuals with visual dysfunction. Products developed must address specific capability gaps and directly benefit military Service members, Veterans, and other affected individuals. The ultimate purpose of this award is to generate research results sufficient to enable Investigational Device Exemption (IDE), Investigational New Drug (IND) applications, or advance to clinical trials, ensuring tangible progress towards real-world clinical applications.
Opportunity ID: 293862
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-VRP-TTDA |
| Funding Opportunity Title: | DoD Vision Research Program, Technology/ Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 15, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 25, 2017 |
| Current Closing Date for Applications: | Oct 25, 2017 |
| Archive Date: | Nov 24, 2017 |
| Estimated Total Program Funding: | $15,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The FY17 VRP TTDA is a mission-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including detection, diagnosis, treatment, or quality of life, in at least one of the FY17 VRP TTDA Capability Gaps. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and other individuals living with visual dysfunction. NOTE: In keeping with the intent of this award mechanism, at the end of this award’s period of performance, research results should be sufficient to support an Investigational Device Exemption (IDE), Investigational New Drug (IND), or continue to clinical trials (where applicable). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 293862 Full Announcement-FY17 VRP TTTDA -> VRP_FY17_TTDA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00232554 | May 15, 2017 | Oct 25, 2017 | View |
Package 1
Mandatory forms
293862 RR_SF424_2_0-2.0.pdf
293862 RR_Budget_1_4-1.4.pdf
293862 RR_KeyPersonExpanded_2_0-2.0.pdf
293862 PerformanceSite_2_0-2.0.pdf
293862 AttachmentForm_1_2-1.2.pdf
Optional forms
293862 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
